Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata. - King, Brett; McMichael, Amy; Sinclair, Rodney; Vañó-Galvan, Sergio; Wolk, Robert; Woodworth, Deborah; Soma, Koshika; Robbana, Feriel; Lejeune, Alexandre; Napatalung, Lynne; Law, Ernest; Wajsbrot, Dalia; et al. (Dermatology & Therapy, 2025)